NR1H4 and metabolic dysfunction-associated steatotic liver disease: An animal experimental research article published in GUT in 2018 was also ranked first this study suggested that intervention in NAFLD can be achieved by targeting the FXR signalling pathway including bile acid conversion and gut microbiota.22